<SEC-DOCUMENT>0001193125-25-004431.txt : 20250110
<SEC-HEADER>0001193125-25-004431.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110160356
ACCESSION NUMBER:		0001193125-25-004431
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250110
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARGO Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001966494
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				844080422
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41859
		FILM NUMBER:		25522846

	BUSINESS ADDRESS:	
		STREET 1:		835 INDUSTRIAL ROAD, SUITE 400
		CITY:			SAN CARLOS
		STATE:			CA
		ZIP:			94070
		BUSINESS PHONE:		650-499-8950

	MAIL ADDRESS:	
		STREET 1:		835 INDUSTRIAL ROAD, SUITE 400
		CITY:			SAN CARLOS
		STATE:			CA
		ZIP:			94070
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d924537d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:crgx="http://cargo-tx.com/20250110" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-277">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-01-10_to_2025-01-10">0001966494</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="crgx-20250110.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-01-10_to_2025-01-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001966494</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-10</xbrli:startDate> <xbrli:endDate>2025-01-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-288">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt:datemonthdayyearen" id="ixv-289">January&#160;10, 2025</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-290">CARGO Therapeutics, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:stateprovnameen" id="ixv-291">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-292">001-41859</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-293">84-4080422</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-294">835 Industrial Road</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-295">Suite 400</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-296">San Carlos</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:stateprovnameen" id="ixv-297">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-298">94070</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-299">(650)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-300">499-8950</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-301">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-302">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-303">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-304">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title&#160;of&#160;each&#160;class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name&#160;of&#160;each&#160;exchange<br/>on which&#160;registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-305">Common stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-306">CRGX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:exchnameen" id="ixv-307">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#8201;240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-308">&#9746;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-309">&#9744;</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;2.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with its participation in the 43<sup style="font-size:75%; vertical-align:top">rd</sup> Annual J.P. Morgan Healthcare Conference,&#160;on January&#160;10, 2025, CARGO Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release announcing certain corporate updates, anticipated milestones for 2025, and estimated cash, cash equivalents and marketable securities of approximately $368.1&#160;million as of December&#160;31, 2024. The Company&#8217;s actual cash, cash equivalents, marketable securities as of December&#160;31, 2024 may differ from this estimate due to the completion of the Company&#8217;s <span style="white-space:nowrap">year-end</span> closing and auditing procedures. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Spokespersons of the Company will be presenting the information provided in this item 2.02 of this Form <span style="white-space:nowrap">8-K</span> at various upcoming meetings beginning January&#160;13, 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information provided in this Item 2.02 of this Current Report on <span style="white-space:nowrap">Form&#160;8-K,&#160;including</span> the attached Exhibit 99.1, is being furnished and shall not be deemed to be &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d924537dex991.htm">Press Release, dated January&#160;10, 2025.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">CARGO&#160;THERAPEUTICS,&#160;INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date:&#8194; January&#160;10, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gina Chapman</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Gina Chapman</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d924537dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g924537g0110194333458.jpg" ALT="LOGO" STYLE="width:1.36319in;height:0.413194in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>- 71 patients dosed in the potentially pivotal Phase 2 clinical study of firicabtagene autoleucel <FONT STYLE="white-space:nowrap">(firi-cel);</FONT>
Interim analysis results expected to be reported in 1H&#146;25 - </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>- IND application for <FONT STYLE="white-space:nowrap">CRG-023,</FONT>
CARGO&#146;s <FONT STYLE="white-space:nowrap">tri-specific</FONT> CAR T, cleared by the FDA; Phase 1 study enrollment expected to initiate <FONT STYLE="white-space:nowrap">mid-year</FONT> 2025 - </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>- CARGO announces novel allogeneic platform based on a universal allogeneic-enabling vector intended to be paired with any new or existing CAR vector to
create an allogeneic CAR <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy while leveraging existing autologous drug product processes - </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SAN
CARLOS, Calif., January</B><B></B><B>&nbsp;10, 2025</B> &#150; <B><U>CARGO Therapeutics, Inc</U></B><B>. (NASDAQ: CRGX)</B>, a clinical-stage biotechnology company positioned to advance next-generation, potentially curative cell therapies for cancer
patients, today provided a corporate update and anticipated milestones for 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;2024 highlighted our excellence in execution and innovation. We
now have three programs &#150; two clinical-stage with another advancing quickly &#150; all driven by our strong capabilities designing, developing, and delivering next-generation, and potentially curative cell therapies,&#148; said Gina Chapman,
President and Chief Executive Officer of CARGO. &#147;We are on track to report our interim analysis results for <FONT STYLE="white-space:nowrap">FIRCE-1</FONT> in first half 2025. I am also delighted to announce the clearance of our IND for <FONT
STYLE="white-space:nowrap">CRG-023,</FONT> a potentially <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> CAR <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy with Phase 1 enrollment to initiate <FONT
STYLE="white-space:nowrap">mid-year.</FONT> Rapid progression of <FONT STYLE="white-space:nowrap">CRG-023</FONT> from lead construct to IND submission in less than 12 months was enabled by our robust CMC and
<FONT STYLE="white-space:nowrap">pre-clinical</FONT> development capabilities. Finally, I&#146;m very excited to announce our novel allogeneic platform, which I believe can meaningfully improve the availability of potentially curative cell therapies
for patients by realizing the promise of an allogeneic solution in a universally applicable way. I&#146;d like to thank the entire CARGO organization for their tenacity and innovative spirit, positioning us for our important milestones this
year.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The challenges that limit a broader impact for autologous cell therapy include the quality of T cells
derived from sick patients and availability of product. For allogeneic cell therapy, durable efficacy has been difficult to achieve,&#148; said Michael Ports, Chief Scientific Officer of CARGO. &#147;Over the past three years, we set out to solve
these limitations through sophisticated cell therapy design and engineering, starting with <FONT STYLE="white-space:nowrap">CRG-023</FONT> and now with our novel allogenic platform that is intended to address immune-based rejection of allogeneic CAR
T. The allogeneic CAR T platform is comprised of a universal vector with multiple transgene &#147;cargo&#148; to limit T and NK rejection and downregulate TCR. Importantly, the vector can be paired with
<FONT STYLE="white-space:nowrap">pre-existing</FONT> CAR vectors across targets and indications and can leverage existing autologous drug product processes. We are encouraged by our preclinical results which suggest the potential of a universal
approach to creating <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> allogeneic CAR T products to provide more life-saving therapies for patients.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Update and Anticipated Milestones for 2025: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Firi-cel</FONT></B>: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As of December&nbsp;31, 2024, 71 patients have been dosed in the potentially pivotal Phase 2 study of <FONT
STYLE="white-space:nowrap">firi-cel,</FONT> <FONT STYLE="white-space:nowrap">FIRCE-1.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CARGO continues to achieve strong manufacturing success of <FONT STYLE="white-space:nowrap">firi-cel.</FONT> The
Company is partnering with National Resilience, Inc. and ElevateBio to manufacture drug product for the <FONT STYLE="white-space:nowrap">FIRCE-1</FONT> study. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CARGO expects to share topline data from an interim analysis for a meaningful patient sample size with at least 3
months of <FONT STYLE="white-space:nowrap">follow-up</FONT> in 1H&#146;25. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">CRG-023</FONT></B>: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In January, the FDA cleared the Investigational New Drug (IND) application for
<FONT STYLE="white-space:nowrap">CRG-023,</FONT> CARGO&#146;s novel <FONT STYLE="white-space:nowrap">tri-specific</FONT> CAR T that is designed to address several known causes of relapse, resulting in a potential <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">best-in-class</FONT></FONT> CAR <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy across a broad range of <FONT STYLE="white-space:nowrap">B-cell</FONT> malignancies with the goal of providing more patients with a
durable complete response. <FONT STYLE="white-space:nowrap">CRG-023</FONT> is a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-of-its-kind</FONT></FONT></FONT> CAR T to express three
independent CARs (CD19, CD20, CD22) from a single vector, with each CAR having a distinct <FONT STYLE="white-space:nowrap">co-stimulatory</FONT> domain. <FONT STYLE="white-space:nowrap">CRG-023</FONT> lentiviral vector is produced using suspension
culture process which provides a line of sight to commercially suitable expression level. <FONT STYLE="white-space:nowrap">CRG-023</FONT> drug product is produced leveraging CARGO&#146;s internally developed process and analytical methods.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Given the encouraging <FONT STYLE="white-space:nowrap">pre-clinical</FONT> data of
<FONT STYLE="white-space:nowrap">CRG-023,</FONT> CARGO intends to demonstrate the product candidate&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> potential through a Phase 1 dose escalation
study in 3L+ LBCL including CAR <FONT STYLE="white-space:nowrap">T-na&iuml;ve</FONT> patients. The Company plans to leverage <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> data to support moving
quickly into earlier lines of therapy and additional indications in <FONT STYLE="white-space:nowrap">B-cell</FONT> malignancies for <FONT STYLE="white-space:nowrap">CRG-023.</FONT> </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Phase 1, open-label, multi-center, dose escalation and dose expansion study is expected to evaluate the
safety, tolerability, pharmacokinetics, and efficacy of <FONT STYLE="white-space:nowrap">CRG-023</FONT> and to establish the recommended Phase 2 dose of <FONT STYLE="white-space:nowrap">CRG-023.</FONT> Dose escalation will begin at a dose level of
25&nbsp;million cells, which was informed by preclinical data that demonstrated in vivo tumor clearance at low dose levels. Enrollment for the Phase 1 study, including CAR <FONT STYLE="white-space:nowrap">T-na&iuml;ve</FONT> patients, is expected to
initiate <FONT STYLE="white-space:nowrap">mid-year</FONT> 2025. CARGO plans to leverage its established manufacturing and supply chain infrastructure to accelerate readiness for its Phase 1 study. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Novel Allogeneic Platform: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CARGO&#146;s novel allogeneic platform is a universal vector solution designed to limit immune-based rejection
and enable durable response of CAR <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy. Through sophisticated engineering, the differentiated platform aims to transform potentially curative autologous CAR
<FONT STYLE="white-space:nowrap">T-cell</FONT> therapies into allogeneic products for broader patient benefit. The universal, allogeneic-enabling vector is intended to pair with new or clinically established CAR vectors, which can be accomplished
while leveraging existing autologous drug product processes. The result is intended to be an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> allogeneic CAR T product designed to limit rejection, promote
safety, improve the starting quality of T cells, and maintain comparable <FONT STYLE="white-space:nowrap">CAR-mediated</FONT> activity. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To date, CARGO has advanced several lead allogeneic constructs and demonstrated proof of concept in limiting
immune rejection, preventing graft vs. host disease (GvHD), and preserving comparable CAR activity when <FONT STYLE="white-space:nowrap">co-transduced</FONT> with CAR vector utilized for autologous CAR <FONT STYLE="white-space:nowrap">T-cell</FONT>
therapy. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CARGO expects to select the lead vector candidate in 1H&#146;25. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Outlook</B>: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As of December&nbsp;31, 2024, the Company&#146;s preliminary cash, cash equivalents and marketable securities
were $368.1 million<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>, which we believe will be sufficient to fund our expected operations through 2026. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gina Chapman, President and Chief Executive Officer, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January&nbsp;13,
at 10:30 a.m. PT. Interested parties can access the live webcast for the presentation in the Investors section of CARGO&#146;s website under <U>News&nbsp;&amp; Events</U>. A replay of the webcast will be available after the conclusion of the live
presentation for approximately 30 days. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CARGO Therapeutics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CARGO Therapeutics, Inc. is a clinical-stage biotechnology company positioned to advance next-generation, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">best-in-class,</FONT></FONT> and potentially curative cell therapies for cancer patients. CARGO&#146;s programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of
approved cell therapies, including limited durability of effect, safety concerns and availability. CARGO has a growing and focused pipeline that includes firicabtagene autoleucel <FONT STYLE="white-space:nowrap">(firi-cel),</FONT> an autologous CD22
chimeric antigen receptor (CAR) <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy candidate currently in a potentially pivotal Phase 2 clinical study in patients with large <FONT STYLE="white-space:nowrap">B-cell</FONT> lymphoma (LBCL) whose
disease relapsed or was refractory (R/R) to CD19 CAR <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy. CARGO is also preparing to initiate a Phase 1 study for its <FONT STYLE="white-space:nowrap">CRG-023</FONT> product candidate, a
CD19/CD20/CD22 <FONT STYLE="white-space:nowrap">tri-specific</FONT> CAR T developed using a tri-cistronic construct and designed to address several known causes of relapse, resulting in a potential <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">best-in-class</FONT></FONT> CAR <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy across a broad range of <FONT STYLE="white-space:nowrap">B-cell</FONT> malignancies with the goal of providing more patients with a
durable complete response. CARGO&#146;s latest program advancement, a novel allogeneic platform, is a universal vector solution designed to limit immune-based rejection and enable durable response of CAR
<FONT STYLE="white-space:nowrap">T-cell</FONT> therapy. The universal allogeneic-enabling vector is intended to be paired with any CAR vector to create an allogeneic CAR <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy, with the potential to
maintain the efficacy, durability, and safety of autologous cell therapy while broadening availability to more people with cancer. CARGO&#146;s leadership and team have significant experience in designing, developing and delivering oncology and cell
therapy products. For more information, please visit the CARGO Therapeutics website at <U><FONT STYLE="white-space:nowrap">https://cargo-tx.com/</FONT></U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follow us on LinkedIn: <U>CARGO Therapeutics</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follow us on
X (Twitter): <U>@CARGOTx</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><SUP STYLE="font-size:75%; vertical-align:top">(1) </SUP></B>The Company&#146;s actual consolidated cash, cash
equivalents, marketable securities as of December&nbsp;31, 2024 may differ from this preliminary estimate due to the completion of the Company&#146;s <FONT STYLE="white-space:nowrap">year-end</FONT> closing and auditing procedures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E
of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as &#147;aim,&#148; &#147;anticipate,&#148; &#147;assume,&#148; &#147;believe,&#148; &#147;contemplate,&#148;
&#147;continue,&#148; &#147;could,&#148; &#147;design,&#148; &#147;due,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;goal,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;objective,&#148; &#147;plan,&#148; &#147;positioned,&#148;
&#147;potential,&#148; &#147;predict,&#148; &#147;seek,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. All statements other than
statements of historical facts contained in this press release are forward-looking statements. These forward-looking statements include, but are not limited to, statements about: the initiation, timing, progress, advancement, and results of
CARGO&#146;s clinical and preclinical programs; the potential benefits of CARGO&#146;s product candidates; the timing of data reports, including the release of interim data from CARGO&#146;s ongoing Phase 2 clinical trial of <FONT
STYLE="white-space:nowrap">firi-cel;</FONT> CARGO&#146;s strategic plans for its business and product candidates; CARGO&#146;s estimated cash, cash equivalents and marketable securities as of December&nbsp;31, 2024 and CARGO&#146;s expectations that
its current cash, cash equivalents and marketable securities will be sufficient to fund its expected operations through 2026. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could
cause actual results and events to differ materially from those anticipated, including, but not limited to, risks and uncertainties related to: the company&#146;s ability to obtain necessary capital to fund its clinical programs; the early stages of
clinical development of the company&#146;s product candidates and the product candidates involving novel technologies; clinical and preclinical development being a lengthy and expensive process with uncertain outcomes; data from the company&#146;s
clinical trials and preclinical studies, including the performance and characteristics of the company&#146;s product candidates, including any undesirable side effects or other properties discovered or detected in the company&#146;s clinical trials
and preclinical studies; any favorable data from trials conducted by third-parties, including Stanford University or the NCI, may not be replicated in the company&#146;s clinical trials or predictive of future results; the company&#146;s ability to
obtain regulatory approval of and successfully commercialize its product candidates; the company&#146;s reliance on third-party suppliers and manufacturers, including CROs; the outcomes of any future collaboration agreements; and the company&#146;s
ability to adequately maintain intellectual property rights for its product candidates. For a detailed discussion of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as
well as risks relating to CARGO&#146;s business in general, please refer to the risk factors identified in the Company&#146;s filings with the Securities and Exchange Commission (SEC), including but not limited to its Quarterly Report on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended September&nbsp;30, 2024 filed on November&nbsp;12, 2024. Any forward-looking statements that the company makes in this press release are made pursuant to the Private Securities Litigation
Reform Act of 1995, as amended, and speak only as of the date of this press release. Except as required by law, the company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future
events or otherwise. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Denise Powell </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>denise@redhousecomms.com</U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jessica Serra </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">jserra@cargo-tx.com</FONT> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Laurence Watts </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>laurence@newstreetir.com </U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>crgx-20250110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/11/2025 1:47:49 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:crgx="http://cargo-tx.com/20250110"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://cargo-tx.com/20250110"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crgx-20250110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crgx-20250110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>crgx-20250110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/11/2025 1:47:49 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>crgx-20250110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/11/2025 1:47:49 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="crgx-20250110.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g924537g0110194333458.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g924537g0110194333458.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  G ($# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#TCQ%XBOKC
M5!H>B9^T$[9)5Z@]P#VQW-0Q_#R69/-O=5E:Y/)(7< ?J>33/AXBW%_J=]+S
M<%@,GJ-Q)->@5PTJ4<0O:5-;[+L>K7KRP<O84=+;OJW_ )'GD3^(?"6H1PRB
M;4+!S_""V![=P?;I7?HZS1*Z_=<9&1C@T\@'K6?K6H+I>CW5V>L:';[L>!^M
M;PA[)/73\CCJU7B)1]U*6VG4\NU-YK/7KZ33IYVM[.8-DR$A>>GTSQ7K-C=I
M?V$%U']R9 X_$5P7AFQM;CPKJ7VFXB6>^+ ;W (QT/\ WUDUI?#S43-IDVGR
M']Y;/E1_LG_Z^:Y,*^6:OM+7^OD>EF$54INRUIM+U5M_O,[X@6QM=1M+F":6
M-KG*NJN0,C'./QJ=_ FI1Q[[;6Y3*!D!BP_4&CXC_P"MTK_>?_V6MFY\;Z+;
MQMB9Y)%XV!"#GTI.%)UI^T=MNH1J8A8:E[%7O?I?J4?!NN7L]W<Z1J;,]Q;Y
M*NWWN#@@GO\ 6G>*O$EU!>)H^D#=>R8#.HR5ST ]_?M5+P7#<ZAX@O\ 7)8C
M'%*&"Y'4L1T^@%1^$U%YXTU:ZF&Z6,N5SVRV/Y"G&<W3C!/=O7R"=*E&O.JT
MO=2=NG,_TN21?#^YNT\[4M4D-PW)P-V#]3UJ)8_$7A*^C53+J-@YY506P/\
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H);B$I V]6"X )1@=NW&258 GGVHHJ[>\T0W[J9W'R^M%%%9FES__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46164714414096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 10, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001966494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 10,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CARGO Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-4080422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">835 Industrial Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Carlos<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">499-8950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRGX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1'
ML#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,
MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@
M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^
M\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$
M%     @ >X J6I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M2P$"% ,4    " ![@"I::Q,; NX    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " ![@"I:F5R<(Q &  "<)P
M$P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( 'N *EI23,#[@@0  ,T1   8              " @0T(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " ![@"I:GZ ;\+$"  #B#
M#0              @ '%#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( 'N
M*EJ7BKL<P    !,"   +              "  :$/  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( 'N *EH<.&7J/P$  #P"   /              "  8H0  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " ![@"I:)!Z;HJT   #X 0  &@
M            @ 'V$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " ![@"I:99!YDAD!  #/ P  $P              @ ';$@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   E%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d924537d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>crgx-20250110.xsd</File>
    <File>crgx-20250110_lab.xml</File>
    <File>crgx-20250110_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d924537d8k.htm">d924537d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d924537d8k.htm": {
   "nsprefix": "crgx",
   "nsuri": "http://cargo-tx.com/20250110",
   "dts": {
    "schema": {
     "local": [
      "crgx-20250110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "crgx-20250110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "crgx-20250110_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d924537d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-01-10_to_2025-01-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d924537d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-01-10_to_2025-01-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d924537d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cargo-tx.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-25-004431-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-004431-xbrl.zip
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MR[QNMR]6?X79]AWN=H9WO=UJ9PW]_ =02P,$%     @ >X J6K%4$=FJ!@
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MWK0S-<:$=!LF9(>29(=IO@;8MM.;'6$?0%-98B01X-_WR* M!I.%[+9CY2*
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M\(!]8'E]QOZSC]_BD7\ 4$L#!!0    ( 'N *EHKDKAFI!   #%H   .
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MOV.VD[NL3N\#D((GL2<W.R+)" R9D9BZEA4R-P%8=[!!65@\KY]K3128D$"
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MS]VT%1LE?JA@E1;/'&4[>ZTLVV,!B)EEA\G(4_I(U0V8S#B)!H:/?$IM8C,
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M.-",A,!W!\2O%H!&:]F!3#,S \;$UB,]ZY@P2I^C4HH"_'4!/ YYGRM2JQ5
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MZ<%O>,C_JZE_ E!+ 0(4 Q0    ( 'N *EI1\=<Q/P,  $ +   1
M      "  0    !C<F=X+3(P,C4P,3$P+GAS9%!+ 0(4 Q0    ( 'N *EJQ
M5!'9J@8  *1)   5              "  6X#  !C<F=X+3(P,C4P,3$P7VQA
M8BYX;6Q02P$"% ,4    " ![@"I:S'>)U-P$  #W+0  %0
M@ %+"@  8W)G>"TR,#(U,#$Q,%]P<F4N>&UL4$L! A0#%     @ >X J6BN2
MN&:D$   ,6@   X              ( !6@\  &0Y,C0U,S=D.&LN:'1M4$L!
M A0#%     @ >X J6M!;S2^E&   <6H  !$              ( !*B   &0Y
E,C0U,S=D97@Y.3$N:'1M4$L%!@     %  4 0 $  /XX      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d924537d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="crgx-20250110.xsd" xlink:type="simple"/>
    <context id="duration_2025-01-10_to_2025-01-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001966494</identifier>
        </entity>
        <period>
            <startDate>2025-01-10</startDate>
            <endDate>2025-01-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-277">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-01-10_to_2025-01-10"
      id="Hidden_dei_EntityCentralIndexKey">0001966494</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-288">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-289">2025-01-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-290">CARGO Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-291">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-292">001-41859</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-293">84-4080422</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-294">835 Industrial Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-295">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-296">San Carlos</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-297">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-298">94070</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-299">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-300">499-8950</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-301">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-302">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-303">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-304">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-305">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-306">CRGX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-307">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-308">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-309">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
